SCHEMBL13863393

SCHEMBL13863393

Cc1ccc(C=Cc2ccc(C=O)cc2)cc1

nearest known ligand 0.84

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP2A6 P11509 3/20 0.84
▸ NFE2L2 Q16236 4/20 0.58
▸ RELA Q04206 1/20 0.54
▸ FBP1 P09467 1/20 0.50
▸ ALOX5 P09917 1/20 0.50
▸ PTGS1 P23219 1/20 0.50
▸ PTGS2 P35354 1/20 0.50
▸ MAPT P10636 1/20 0.48
▸ CA1 P00915 1/20 0.48
▸ ALDH1A1 P00352 2/20 0.46
▸ TYR P14679 1/20 0.46
▸ CYP2A13 Q16696 1/20 0.46
▸ HSD17B10 Q99714 1/20 0.46
▸ ALDH5A1 P51649 1/20 0.46
▸ ABAT P80404 1/20 0.46
▸ KDM4E B2RXH2 1/20 0.46
▸ NPC1 O15118 1/20 0.46
▸ LMNA P02545 1/20 0.46
▸ CYP1A2 P05177 1/20 0.46
▸ POLB P06746 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12922328 1.00 CYP2A6 (0.84) CYP2A6NFE2L2RELAFBP1ALOX5
SCHEMBL13969754 1.00 CYP2A6 (0.84) CYP2A6NFE2L2RELAFBP1ALOX5
SCHEMBL8469408 0.92 CYP2A6 (1.00) CYP2A6NFE2L2FBP1ALDH1A1TYR
P-Xylene SCHEMBL10939332 0.92 CYP2A6 (1.00) CYP2A6NFE2L2FBP1ALDH1A1TYR
SCHEMBL29171 0.92 — —
SCHEMBL586152 0.89 CYP2A6 (0.94) CYP2A6NFE2L2FBP1ALDH1A1TYR
Iodide SCHEMBL34461933 0.89 CYP2A6 (0.94) CYP2A6NFE2L2FBP1ALDH1A1TYR
SCHEMBL586330 0.89 CYP2A6 (0.94) CYP2A6NFE2L2FBP1ALDH1A1TYR
Hydrochloric Acid SCHEMBL14686576 0.89 CYP2A6 (0.94) CYP2A6NFE2L2FBP1ALDH1A1TYR
SCHEMBL28788188 0.89 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090124838-A1 LIQUID CRYSTALLINE STYRYL DERIVATIVE, PROCESS OF PREPARING SAME, AND LIQUID CRYSTAL SEMICONDUCTOR DEVICE USING SAME YAMANASHI UNIVERSITY (JP) 2009-05-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090124838-A1 LIQUID CRYSTALLINE STYRYL DERIVATIVE, PROCESS OF PREPARING SAME, AND LIQUID CRYSTAL SEMICONDUCTOR DEVICE USING SAME SCO2, SMYD2, SMYD3 CYP2A6 3348/4885NFE2L2 1359/4885RELA 1883/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback